5Lode H. Evidence of dittbrent profiles of side effeets and drug-drug interaclions among the quinolones the pharmacokinetic standpoint [J]. Cbemotherapy, 2001, 47 (Suppl 3): 24-31.
6Niki Y, Hashiguchi K, Miyashita N. Influence of gati- floxacin, a new quinolone amibacterial. on pharmacoki- netics of theophylline [J]. J Infect Chemother, 1999, 5 (3): 156-62.
